Literature DB >> 6374610

Oral controlled release dosage forms. A review.

P De Haan, C F Lerk.   

Abstract

When a drug meets the criteria which make incorporation into a controlled release dosage form rational, a proper dosage form has to be selected. Oral controlled release products, available on the Dutch market, are referred to in discussing the various methods used to control drug release by galenical means in order to achieve a prolonged therapeutic effect. The effects of some physiological variables of the alimentary tract on drug delivery from the various dosage forms, especially with regard to formulation and design, are reviewed.

Mesh:

Substances:

Year:  1984        PMID: 6374610     DOI: 10.1007/bf01953956

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  79 in total

1.  Physiologic availability and in vitro release of riboflavin in sustained-release vitamin preparations.

Authors:  A B MORRISON; C B PERUSSE; J A CAMPBELL
Journal:  N Engl J Med       Date:  1960-07-21       Impact factor: 91.245

2.  The gastric secretion of drugs: a pH partition hypothesis.

Authors:  P A SHORE; B B BRODIE; C A HOGBEN
Journal:  J Pharmacol Exp Ther       Date:  1957-03       Impact factor: 4.030

3.  Absorption of drugs from the rat small intestine.

Authors:  L S SCHANKER; D J TOCCO; B B BRODIE; C A HOGBEN
Journal:  J Pharmacol Exp Ther       Date:  1958-05       Impact factor: 4.030

4.  Measurement of gastric functions during digestion of ordinary solid meals in man.

Authors:  J R Malagelada; G F Longstreth; W H Summerskill; V L Go
Journal:  Gastroenterology       Date:  1976-02       Impact factor: 22.682

Review 5.  Oral controlled release preparations.

Authors:  C R García; A Siqueiros; L Z Benet
Journal:  Pharm Acta Helv       Date:  1978

6.  Blood levels and management of lithium treatment.

Authors:  J L Crammer; R M Rosser; G Crane
Journal:  Br Med J       Date:  1974-09-14

7.  Editorial: Single daily dose of antidepressants.

Authors:  F J Ayd
Journal:  JAMA       Date:  1974-10-14       Impact factor: 56.272

8.  Spray-congealed formulations of sulfaethidole (SETD) and waxes for prolonged-release medication. Effect of modifiers.

Authors:  Y Raghunathan; C H Becker
Journal:  J Pharm Sci       Date:  1968-10       Impact factor: 3.534

9.  [On the manufacture and testing of butaperazine matrix tablets with silicone varnish NH 30 as a structural substance (author's transl)].

Authors:  H Kala; D Wendorff; H Moldenhauer
Journal:  Pharmazie       Date:  1980       Impact factor: 1.267

10.  Bioavailability of indomethacin from two multiple-units controlled-release formulations.

Authors:  H Bechgaard; R R Brodie; L F Chasseaud; P Houmøller; J O Hunter; P Siklos; T Taylor
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more
  11 in total

1.  Comparison of the pharmacokinetics of a new 30 mg modified-release tablet formulation of metoclopramide for once-a-day administration versus 10 mg immediate-release tablets: a single and multiple-dose, randomized, open-label, parallel study in healthy male subjects.

Authors:  Roberto Bernardo-Escudero; Rosalba Alonso-Campero; María Teresa de Jesús Francisco-Doce; Myriam Cortés-Fuentes; Miriam Villa-Vargas; Juan Angeles-Uribe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-02-11       Impact factor: 2.441

Review 2.  Controlled release systems containing solid dispersions: strategies and mechanisms.

Authors:  Phuong Ha-Lien Tran; Thao Truong-Dinh Tran; Jun Bom Park; Beom-Jin Lee
Journal:  Pharm Res       Date:  2011-05-07       Impact factor: 4.200

3.  Comparison of a controlled-release tablet of salbutamol given twice daily with a standard tablet given four times daily in the management of chronic obstructive lung disease.

Authors:  F P Maesen; J J Smeets
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Design and in vitro evaluation of dapsone-loaded micropellets of ethyl cellulose.

Authors:  S Roy; S K Das; M Pal; B K Gupta
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

5.  An Investigation on the Effect of Polyethylene Oxide Concentration and Particle Size in Modulating Theophylline Release from Tablet Matrices.

Authors:  Saeed Shojaee; Parastou Emami; Ahmad Mahmood; Yemisi Rowaiye; Alusine Dukulay; Waseem Kaialy; Iain Cumming; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2015-03-14       Impact factor: 3.246

Review 6.  Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review.

Authors:  Kaushika Patel; Shreeraj Shah; Jaymin Patel
Journal:  Daru       Date:  2022-04-18       Impact factor: 4.088

7.  Attitude and perception of patients and health care practitioners toward oral sustained release dosage forms in Palestine.

Authors:  Abdel Naser Zaid
Journal:  Saudi Pharm J       Date:  2010-07-30       Impact factor: 4.330

8.  Development of a Sustained Release Solid Dispersion Using Swellable Polymer by Melting Method.

Authors:  Tuong Ngoc-Gia Nguyen; Phuong Ha-Lien Tran; Toi Van Vo; Wei Duan; Thao Truong-Dinh Tran
Journal:  Pharm Res       Date:  2015-08-12       Impact factor: 4.200

9.  Development, Internal and External Validation of Naproxen Sodium Sustained Release Formulation: an Level A In Vitro-In Vivo Correlation.

Authors:  Ramesh Narayanasamy; Ramakrishna Shabaraya
Journal:  Turk J Pharm Sci       Date:  2017-08-15

10.  Sustained-release solid dispersion of pelubiprofen using the blended mixture of aminoclay and pH independent polymers: preparation and in vitro/in vivo characterization.

Authors:  Yeo-Song Lee; Jae Guen Song; Sang Hoon Lee; Hyo-Kyung Han
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.